Publications & News

endogene.bio selected for Lilly Gateway Labs

endogene.bio has been selected for the inaugural virtual Eli Lilly and Company Gateway Labs program, a 12-month accelerator that kicked off in London last week. Through the program, we'll benefit fro…

Whole genome methylation profiling of menstrual stem cells identifies novel biomarkers for endometriosis

endogene.bio named finalist in the 2026 Hello Tomorrow Challenge

endogene.bio has been named a finalist in the 2026 Hello Tomorrow Challenge, one of the world's leading deep tech competitions. The company has been selected within the Medical Biotech & Pharmaceutica…

Advancing biomarker research in endometriosis at SEUD 2026

At SEUD 2026, endogene.bio shared new research on molecular profiling from menstrual blood and its potential to improve our understanding of patient heterogeneity and treatment response in endometrios…

POSTER: SEUD 2026 (Germany)

Launching new clinical study

Building on previous studies, endogene.bio is launching a new clinical study in endometriosis to expand patient cohorts and deepen our understanding of disease biology. The study will support ongoing…

Continuing partnership to advance menstrual health research

endogene.bio is renewing its collaboration with Asan Cups, whose mission to improve access to menstrual health closely aligns with our own. Together, we will support clinical research and contribute…

endogene.bio selected as a Hello Tomorrow Deep Tech Pioneer

endogene.bio has been selected as one of the Hello Tomorrow Deep Tech Pioneers, recognizing the scientific depth and innovation behind our approach to advancing precision medicine in uterine health.…

Featured in STAT: The case for earlier diagnosis in endometriosis

Our CEO María Teresa Pérez Zaballos and Head of Science Cristina Fernández Molina explain why earlier, non-invasive diagnosis isn’t just possible, it’s essential.

Why we menstruate: the evolutionary logic of a costly system

Beyond one-size-fits-all: single-cell transcriptomic signatures predict drug efficacy and reveal responder subgroups in endometriosis

Whole-genome methylation profiling of menstrual stem cells identifies novel biomarkers for endometriosis

POSTER: 16th World Congress on Endometriosis (Australia)

endogene.bio secures funding from BPI Innov'up

endogene.bio was awarded funding through Innov'up, a program supported by Bpifrance that provides financial and strategic support to high-potential innovative companies. Designed to accelerate the dev…

endogene.bio wins the national i-Lab competition

endogene.bio was selected as one of the winners of the 2024 i-Lab competition, a national innovation program organized by Bpifrance as part of the France 2030 initiative. The i-Lab competition is dedi…

endogene.bio co-founders mentors at Cambridge FemTech Society

The Cambridge FemTech Society is launching its 3rd Annual FemTech Entrepreneurship Weekend on March 15, 2024. This event brings together the best elements of a hackathon, an innovation workshop, and e…

Special screening of 'Below the Belt' for International Women's Day

In honor of International Women's Day and Endometriosis Awareness Month, Zinc VC and Frontline Ventures hosted a special screening of Below the Belt: The Last Health Taboo, a powerful documentary that…

endogene.bio wins the Golden Pretzel Pitch at Bits & Pretzels

Bits & Pretzels brings together 5,000 founders, investors, enthusiasts and industry leaders from the global startup ecosystem for three days of learning, networking and business during Munich's Oktobe…